Efficacy and long-term outcome of acquired chronic pure red cell aplasia in adults

Efficacy and long-term outcome of acquired chronic pure red cell aplasia in adults - Zouketsushougaihan pure red cell aplasia cohort study (PRCA2016)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024807

Enrollment

100

Registered

2016-12-01

Start date

2016-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired chronic pure red cell aplasia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acquired chronic pure red cell aplasia

Exclusion criteria

Exclusion criteria: Acute pure red cell aplasia, congenital pure red cell aplasia

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Response rate of immunosuppressive therapy, efficacy of iron-chelation therapy in transfusion-dependent patients	—

Countries

Japan

Contacts

Public ContactKaoko Sakai

Shinshu University School of Medicine Department of Hematology

kaokos@shinshu-u.ac.jp0263-37-2554

Outcome results